Opportunity Information: Apply for CDC RFA PS09 912
Apply for CDC RFA PS09 912
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Provision of HIV/AIDS and TB related laboratory support and technical assistance services in the Kingdom of Swaziland under the President s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Mar 31, 2009 and posted on Mar 31, 2009.
- Applicants must submit their applications by May 29, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $400,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $400,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: For profit organizations other than small businesses City or township governments County governments Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) State governments Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public and State controlled institutions of higher education Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Centers for Disease Control and Prevention (CDC), through its Procurement and Grants Office, released a discretionary funding opportunity under PEPFAR titled "Provision of HIV/AIDS and TB related laboratory support and technical assistance services in the Kingdom of Swaziland." The award is structured as a cooperative agreement, meaning the recipient would not only receive funding but would also work in close collaboration with CDC on planning, implementation, and oversight. The opportunity was posted on March 31, 2009 under Funding Opportunity Number CDC RFA PS09-912, with applications due May 29, 2009. The total funding amount available was approximately USD 400,000, with an award ceiling of USD 400,000, and CDC expected to make about one award. The anticipated funding start was projected to occur before September 30, 2009. No cost sharing or matching funds were required, which lowers the financial barrier for applicants and makes the award primarily performance- and capacity-driven.
The central goal of the grant is to strengthen national laboratory systems in Swaziland (now Eswatini) in support of HIV/AIDS and tuberculosis programs, specifically by providing technical assistance and operational support to the Ministry of Health and Social Welfare (MOHSW). The work is focused in particular on the National Clinical Laboratory Services, which typically functions as the backbone of testing, quality oversight, and diagnostic standardization in a public health system. In practical terms, the award is meant to help improve how laboratories across the country operate, how they ensure reliable results, and how they introduce or upgrade diagnostic methods that are essential for HIV and TB prevention, treatment, and monitoring.
The announcement highlights two major intended outcomes. First, it aims to ensure the development of a nationwide laboratory quality assurance (QA) and quality management system (QMS). This generally involves building standardized procedures and oversight mechanisms so that labs, regardless of location or workload, follow consistent practices for sample handling, testing protocols, equipment calibration, staff competency, documentation, and corrective actions when errors occur. A national QA/QMS effort often includes creating or strengthening standard operating procedures, implementing internal quality control checks, organizing external quality assessment or proficiency testing, and establishing routine supervisory and audit processes that can be applied across a tiered lab network. The intent is to reduce variability in test performance, prevent avoidable errors, and increase confidence that results used for clinical decisions and surveillance are accurate and comparable across facilities.
Second, the grant seeks to enhance and improve existing diagnostic procedures and support the introduction of new diagnostic practices relevant to HIV and TB. This can include improving the performance and reliability of routine tests already in use and helping the national system adopt newer or more effective diagnostics where appropriate. In the HIV context, this commonly ties to tests that support patient management and program monitoring, while in the TB context it often includes improvements that reduce delays in diagnosis and strengthen detection. The emphasis is not simply on purchasing equipment, but on the technical and operational support needed to implement diagnostics well: method validation, staff training, workflow improvements, maintenance planning, quality control integration, and ensuring that new procedures are feasible and sustainable within the country system.
Eligibility for the opportunity was broad, covering many types of organizations capable of delivering technical assistance at national scale. Eligible applicants included for-profit entities (including small businesses and other for-profit organizations), nonprofits (both 501(c)(3) and non-501(c)(3)), public and private institutions of higher education, and various levels of government (state, county, city/township, and special district governments), as well as Native American tribal governments and tribal organizations. The funding activity category is health, and the CFDA number listed is 93.067 (Global AIDS), which aligns the program squarely within PEPFAR-supported HIV systems strengthening, with a clear link to TB due to the overlapping burden and the shared laboratory infrastructure required for both diseases.
Applicants who could not access the full announcement electronically were directed to contact CDC's Technical Information Management Section (PGOTIMS) by phone at 770-488-2700. The summary information indicates that the detailed scope of work, specific deliverables, and reporting expectations were contained in the full announcement, but the core thrust is clear: build a countrywide laboratory quality framework and strengthen diagnostic capacity so that HIV and TB services in Swaziland are supported by accurate, standardized, and scalable laboratory systems.
Frequently Asked Questions (FAQs)
What is the title of this CDC funding opportunity?
The opportunity is titled "Provision of HIV/AIDS and TB related laboratory support and technical assistance services in the Kingdom of Swaziland."
Which federal agency released this opportunity?
The Centers for Disease Control and Prevention (CDC), through its Procurement and Grants Office, released the funding opportunity.
What program is this opportunity associated with?
It is a PEPFAR discretionary funding opportunity and is aligned with CFDA 93.067 (Global AIDS), with an explicit laboratory connection to both HIV/AIDS and tuberculosis (TB).
What is the Funding Opportunity Number?
The Funding Opportunity Number is CDC RFA PS09-912.
When was the opportunity posted?
The opportunity was posted on March 31, 2009.
When were applications due?
Applications were due May 29, 2009.
What type of award is this?
This award is structured as a cooperative agreement.
What does it mean that this is a cooperative agreement?
A cooperative agreement means the recipient would receive funding and would also work in close collaboration with CDC on planning, implementation, and oversight.
How much total funding was available under this opportunity?
The total funding amount available was approximately USD 400,000.
What is the award ceiling?
The award ceiling was USD 400,000.
How many awards did CDC expect to make?
CDC expected to make about one award.
When was the funding expected to start?
The anticipated funding start was projected to occur before September 30, 2009.
Was cost sharing or matching required?
No. The opportunity stated that no cost sharing or matching funds were required.
What is the central goal of the grant?
The central goal is to strengthen national laboratory systems in Swaziland (now Eswatini) in support of HIV/AIDS and TB programs by providing technical assistance and operational support to the Ministry of Health and Social Welfare (MOHSW).
Which national entity is the work intended to support?
The work is intended to support the Ministry of Health and Social Welfare (MOHSW), with a focus on strengthening the National Clinical Laboratory Services.
What part of the laboratory system is specifically highlighted?
The announcement specifically highlights the National Clinical Laboratory Services as a focal point for strengthening national laboratory operations, quality oversight, and diagnostic standardization.
What are the major intended outcomes of the grant?
The announcement highlights two major intended outcomes: (1) development of a nationwide laboratory quality assurance (QA) and quality management system (QMS), and (2) enhancement of existing diagnostic procedures and support for introducing new diagnostic practices relevant to HIV and TB.
What does a nationwide QA/QMS effort generally involve in this opportunity?
Based on the announcement summary, a nationwide QA/QMS effort generally involves building standardized procedures and oversight mechanisms so labs follow consistent practices for sample handling, testing protocols, equipment calibration, staff competency, documentation, and corrective actions when errors occur.
What kinds of quality activities are implied by the QA/QMS outcome?
The summary indicates activities such as creating or strengthening standard operating procedures, implementing internal quality control checks, organizing external quality assessment or proficiency testing, and establishing routine supervisory and audit processes across a tiered laboratory network.
Why is national QA/QMS important for HIV and TB laboratory services?
The intent is to reduce variability in test performance, prevent avoidable errors, and increase confidence that results used for clinical decisions and surveillance are accurate and comparable across facilities.
What does the diagnostic strengthening outcome cover?
The opportunity seeks to enhance and improve existing diagnostic procedures and support the introduction of new diagnostic practices relevant to HIV and TB, including improving routine tests and helping adopt newer or more effective diagnostics where appropriate.
Is the opportunity mainly about purchasing laboratory equipment?
No. The emphasis is not simply on purchasing equipment, but on the technical and operational support needed to implement diagnostics well, such as method validation, staff training, workflow improvements, maintenance planning, and quality control integration.
What is the geographic focus of the work?
The work is focused on strengthening laboratory systems in the Kingdom of Swaziland (now Eswatini).
What is the funding activity category?
The funding activity category is health.
Who was eligible to apply?
Eligibility was broad and included for-profit entities (including small businesses and other for-profit organizations), nonprofits (501(c)(3) and non-501(c)(3)), public and private institutions of higher education, and government entities (state, county, city/township, and special district governments), as well as Native American tribal governments and tribal organizations.
How can an applicant request the full announcement if they cannot access it electronically?
Applicants who could not access the full announcement electronically were directed to contact CDC's Technical Information Management Section (PGOTIMS) by phone at 770-488-2700.
Where are the detailed scope of work, deliverables, and reporting expectations described?
The summary information indicates that detailed scope of work, specific deliverables, and reporting expectations were contained in the full announcement.
What does the summary say is the overall thrust of the work?
The summary describes the overall thrust as building a countrywide laboratory quality framework and strengthening diagnostic capacity so HIV and TB services are supported by accurate, standardized, and scalable laboratory systems.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Developing Advanced Laboratory Systems in the Socialist Republic of Vietnam under the President s Emergency Plan for AIDS Relief (PEPFAR)
Previous opportunity: Undergraduate International Studies and Foreign Language Program CFDA 84.016A
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS09 912
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS09 912) also looked into and applied for these:
| Funding Opportunity |
|---|
| Developing Advanced Laboratory Systems in the Socialist Republic of Vietnam under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS09 9106 Funding Number: CDC RFA PS09 9106 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $325,000 |
| Building and Improving Laboratory Capacity and Quality in the Kingdom of Lesotho under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS09 923 Funding Number: CDC RFA PS09 923 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,105,000 |
| Support to the Ministry of Health and Social Welfare to Strengthen Health Systems and Coordinate HIV/AIDS Prevention, Care and Treatment Programs in the Kingdom of Lesotho under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS09 924 Funding Number: CDC RFA PS09 924 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $255,000 |
| Support for a Comprehensive HIV and AIDS Program at the District Level in the Republic of South Africa under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS09 931 Funding Number: CDC RFA PS09 931 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
| HIV Prevention among Students and Faculty at Pre Service Institutions in the Republic of Mozambique under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS09 943 Funding Number: CDC RFA PS09 943 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Implementation of a Primary Health Care Program in South Africa under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS09 951 Funding Number: CDC RFA PS09 951 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,500,000 |
| Implementation of an HIV Care and Support Program in the Republic of South Africa under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS09 956 Funding Number: CDC RFA PS09 956 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Strengthening Public Health Laboratory Systems in the Republic of Kenya under the President s Emergency Fund for AIDS Relief (PEPFAR) Apply for CDC RFA PS09 965 Funding Number: CDC RFA PS09 965 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,800,000 |
| Part C EIS CATEGORICAL GRANT PROGRAM TO PROVIDE OUTPATIENT EARLY INTERVENTION SERVICES WITH RESPECT TO HIV DISEASE Apply for HRSA 10 007 Funding Number: HRSA 10 007 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Novel statistical methods for human gene expression quantitative trait loci (eQTL) analysis (R01) Apply for RFA RM 09 006 Funding Number: RFA RM 09 006 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| FY 2009 CONGRESSIONAL EARMARKS (CEA) Apply for HHS 2009 CMS CEA 0007 Funding Number: HHS 2009 CMS CEA 0007 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $666,000 |
| Grants to Support the Hispanic Health Services Research Grant Program Apply for HHS 2009 CMS HHS 0005 Funding Number: HHS 2009 CMS HHS 0005 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $100,000 |
| Coordinating Center for Organ Transplant Clinical Trials (U01) Apply for RFA AI 09 015 Funding Number: RFA AI 09 015 Agency: National Institutes of Health Category: Health Funding Amount: $2,500,000 |
| Grants to Support the Historically Black Colleges and Universities Apply for HHS 2009 CMS HBCU 0006 Funding Number: HHS 2009 CMS HBCU 0006 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $100,000 |
| Partnerships for Development of Vaccines for Selected Pathogens (R01) Apply for RFA AI 09 016 Funding Number: RFA AI 09 016 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Sober Truth on Preventing Underage Drinking Act Grants Apply for SP 09 007 Funding Number: SP 09 007 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: Case Dependent |
| NIDCD Definitive Phase III Clinical Trial Planning Grant (R34) Apply for PAR 09 142 Funding Number: PAR 09 142 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Implementation of Programs for the Prevention, Care and Treatment of HIV/AIDS in the United Republic of Tanzania under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 974 Funding Number: CDC RFA PS09 974 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Peer to Peer Capacity Building of Ministries of Health in Public Sector HIV Program Management under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 915 Funding Number: CDC RFA PS09 915 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $7,000,000 |
| Multiplex Assay Development for Arthritis and Musculoskeletal and Skin Diseases (SBIR R43/R44) Apply for PA 09 127 Funding Number: PA 09 127 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS09 912", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.